Apple's new thought control protocol has now been shown in use by Synchron, a medical company that has made a prototype for using iPads solely by thinking. By @WGallagher https://t.co/Simwvv07VP
Watch Brain-Controlled iPad in Action for the First Time https://t.co/a310z9jCso https://t.co/Sq0NZZrsaW
Synchron Debuts First Thought-Controlled iPad Experience Using Apple’s New BCI Human Interface Device Protocol https://t.co/tp2KltMHH2
Neuralink, the brain implant company founded by Elon Musk, has launched a clinical study in Great Britain in partnership with University College London Hospitals (UCLH) and Newcastle Hospitals. The study aims to explore how Neuralink's brain-computer interface (BCI) can restore digital autonomy to individuals with severe paralysis by enabling them to control digital and physical devices using their thoughts. This marks Neuralink's entry into the UK clinical research landscape. The initiative is part of broader advancements in brain-computer interface technology, including parallel developments by other companies such as Synchron, which recently demonstrated the first thought-controlled iPad experience using Apple's new BCI Human Interface Device protocol. The UK government is also working to reduce the time required to establish clinical trials to just 10 weeks, potentially facilitating faster innovation in this field.